Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial

VITIELLO, BENEDETTO;
2008-01-01

2008
299
8
901
913
http://jama.ama-assn.org/cgi/reprint/299/8/901
Adolescent; Citalopram; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Drug Resistance; Female; Fluoxetine; Humans; Male; Paroxetine; Serotonin Uptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Cognitive Therapy; Medicine (all)
Brent, David; Emslie, Graham; Clarke, Greg; Wagner, Karen Dineen; Asarnow, Joan Rosenbaum; Keller, Marty; Vitiello, Benedetto; Ritz, Louise; Iyengar, Satish; Abebe, Kaleab; Birmaher, Boris; Ryan, Neal; Kennard, Betsy; Hughes, Carroll; Debar, Lynn; Mccracken, James; Strober, Michael; Suddath, Robert; Spirito, Anthony; Leonard, Henrietta; Melhem, Nadine; Porta, Giovanna; Onorato, Matthew; Zelazny, Jamie
File in questo prodotto:
File Dimensione Formato  
brent et al.tordia.jama.08.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 177.96 kB
Formato Adobe PDF
177.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1646335
Citazioni
  • ???jsp.display-item.citation.pmc??? 153
  • Scopus 503
  • ???jsp.display-item.citation.isi??? 446
social impact